152 related articles for article (PubMed ID: 32614271)
1. Interleukin-6-Mediated Inflammation May Cause Methotrexate-Induced Leukoencephalopathy.
Asano T; Iguchi A; Miyasho T
J Interferon Cytokine Res; 2020 Jul; 40(7):341-348. PubMed ID: 32614271
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome in a postpartum woman with acute lymphoblastic leukaemia after intrathecal methotrexate.
Mescher C; Slungaard A
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978582
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
4. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
Tsao TF; Chao YH
Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
[No Abstract] [Full Text] [Related]
5. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
7. Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
Summers RJ; Abramowsky CR; Cooper TM
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e19-22. PubMed ID: 23274378
[TBL] [Abstract][Full Text] [Related]
8. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
Agarwal A; Vijay K; Thamburaj K; Ouyang T
Emerg Radiol; 2011 Aug; 18(4):345-7. PubMed ID: 21243392
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-induced posterior reversible encephalopathy syndrome.
Aradillas E; Arora R; Gasperino J
J Clin Pharm Ther; 2011 Aug; 36(4):529-36. PubMed ID: 21210832
[TBL] [Abstract][Full Text] [Related]
10. Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.
Dufourg MN; Landman-Parker J; Auclerc MF; Schmitt C; Perel Y; Michel G; Levy P; Couillault G; Gandemer V; Tabone MD; Demeocq F; Vannier JP; Leblanc T; Leverger G; Baruchel A
Leukemia; 2007 Feb; 21(2):238-47. PubMed ID: 17170721
[TBL] [Abstract][Full Text] [Related]
11. MRI findings in methotrexate-induced acute toxic leukoencephalopathy.
Jakkani RK; Krishna Reddy GV; Anasuri S; Suvarna H; Kumar MS; Satyanarayan S
Neurol India; 2017; 65(6):1439-1440. PubMed ID: 29133739
[No Abstract] [Full Text] [Related]
12. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
Tsujimoto S; Yanagimachi M; Tanoshima R; Urayama KY; Tanaka F; Aida N; Goto H; Ito S
Pediatr Blood Cancer; 2016 Nov; 63(11):1983-9. PubMed ID: 27399166
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.
Reddick WE; Glass JO; Helton KJ; Langston JW; Xiong X; Wu S; Pui CH
AJNR Am J Neuroradiol; 2005 May; 26(5):1263-9. PubMed ID: 15891195
[TBL] [Abstract][Full Text] [Related]
14. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate leukoencephalopathy mimics acute progressive stroke.
Tanaka R; Sasaki-Ikesawa K; Shimura H; Nishioka K; Hattori N; Tanaka S
J Neurol; 2011 Nov; 258(11):2083-5. PubMed ID: 21512738
[No Abstract] [Full Text] [Related]
16. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
17. [Methotrexate-induced interstitial pneumonitis in a child with acute lymphoblastic leukemia].
Tatsumoto C; Kawakami K; Nagayama J; Kawano H
Rinsho Ketsueki; 2004 Oct; 45(10):1100-4. PubMed ID: 15553044
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy.
Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S
Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of leukoencephalopathy and its potential cognitive sequelae in cancer patients.
Schroyen G; Meylaers M; Deprez S; Blommaert J; Smeets A; Jacobs S; Sunaert S; Sleurs C; Uyttebroeck A
J Chemother; 2020 Nov; 32(7):327-343. PubMed ID: 32799637
[TBL] [Abstract][Full Text] [Related]
20. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy.
Hamamoto K; Oriuchi N; Kanazawa T; Higuchi T; Endo K
Pediatr Neurol; 2009 Apr; 40(4):306-9. PubMed ID: 19302946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]